Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical Trial.

JAMA network open·2026

Same author

Data and knowledge-driven imaging biomarkers for lumbar aging and degenerative risk stratification monitoring.

NPJ digital medicine·2026

Same author

Environmental stress responses and climate vulnerability of Abies beshanzuensis: combined physiological and transcriptomic analysis.

BMC plant biology·2026

Same author

Cardiac Structural and Functional Evaluation Using a Heart Motion Correction Algorithm for Coronary Computed Tomography Angiography in Patients With High Heart Rates.

Reviews in cardiovascular medicine·2026

Same author

Correction: Alternative polyadenylation and metabolic profiling in young panicle development of hybrid rice and its parents.

Rice (New York, N.Y.)·2026

Same author

Rind-core microbial niche differentiation at centimeter-scale modulates the sensory quality of solid-state high-temperature Daqu.

Food research international (Ottawa, Ont.)·2026

Same journal

Anti-fibrotic therapy in Crohn's disease: hype or reality-can intestinal fibrosis be targeted effectively?

Expert review of gastroenterology & hepatology·2026

Same journal

Management of gastric varices: treatment options and opportunities to improve outcomes.

Expert review of gastroenterology & hepatology·2026

Same journal

Microbial ecology and hepatocellular carcinoma: should a subset be viewed as a microbiome-conditioned malignancy?

Expert review of gastroenterology & hepatology·2026

Same journal

FAPI PET in inflammatory bowel disease: a novel window on fibroblast activity, with unanswered clinical questions.

Expert review of gastroenterology & hepatology·2026

Same journal

Lyon Consensus 2.0: what has changed for GERD diagnosis?

Expert review of gastroenterology & hepatology·2026

Same journal

Proton pump inhibitors in children: indications and safety.

Expert review of gastroenterology & hepatology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 8, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

Gallbladder carcinosarcoma: current perspectives and new development.

Xiaorong Chen¹, Yuwen Zhou², Xinyao Shu¹

¹Department of Abdominal Cancer, Cancer Center, West China Hospital of Sichuan University, Chengdu, China.

Expert Review of Gastroenterology & Hepatology

|April 21, 2021

Summary

This summary is machine-generated.

Gallbladder carcinosarcoma (GBCS) is a rare cancer. This review provides essential information on GBCS epidemiology, diagnosis, and treatment, distinguishing it from gallbladder cancer.

Keywords:

Carcinosarcoma epithelial gallbladder mesenchymal treatment

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor

Published on: May 23, 2025

Related Experiment Videos

Last Updated: Nov 8, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor

Published on: May 23, 2025

Area of Science:

Oncology
Surgical Pathology

Background:

Gallbladder carcinosarcoma (GBCS) is an exceptionally rare malignancy.
Existing literature primarily consists of case reports and series, lacking comprehensive analyses.

Purpose of the Study:

To consolidate current literature on GBCS.
To provide clinicians with accurate information for diagnosis and treatment.
To highlight GBCS as a distinct entity.

Main Methods:

Systematic literature review of PubMed and Medline databases.
Analysis of GBCS epidemiology, mechanisms, clinical presentation, diagnosis, treatment, and prognosis.

Main Results:

GBCS is frequently misdiagnosed as standard gallbladder cancer (GBC).
GBCS exhibits distinct biological behavior and patient outcomes compared to GBC.
Current treatment approaches often mirror those for GBC.

Conclusions:

Gallbladder carcinosarcoma requires recognition as a separate disease entity.
Accurate diagnosis is crucial for appropriate management and improved outcomes.
Further research is needed to understand GBCS biology and optimize treatment strategies.